Stellar Biotechnologies Completes Reverse Merger

Represented Stellar Biotechnologies, Inc. in its reverse merger into a public entity transaction on the TSX Venture Exchange. Stellar Biotechnologies, Inc. is the world leader in sustainable manufacture of KLH, an important immune-stimulating protein used in wide-ranging therapeutic and diagnostic markets.